SolidGel
Fuente:
Zenodo
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Recurso digital |
| Publicado: |
Zenodo
2025
|
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1866901999203647488 |
|---|---|
| author | Qudaih, Nadim |
| author_facet | Qudaih, Nadim |
| contents | <p>SolidGel is an innovative injectable smart hydrogel platform for localized treatment of solid tumors. It combines hyaluronic acid (HA) with nanoclay (Laponite XLG) and a synergistic drug duo—metformin and disulfiram. The hydrogel enables controlled local release, where metformin starves cancer cells and disulfiram, in the presence of copper, selectively kills resistant cancer stem cells. This approach minimizes systemic toxicity while maximizing therapeutic efficacy, offering a cost-effective and clinically translatable solution for solid tumor therapy.</p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_16954011 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | SolidGel Qudaih, Nadim <p>SolidGel is an innovative injectable smart hydrogel platform for localized treatment of solid tumors. It combines hyaluronic acid (HA) with nanoclay (Laponite XLG) and a synergistic drug duo—metformin and disulfiram. The hydrogel enables controlled local release, where metformin starves cancer cells and disulfiram, in the presence of copper, selectively kills resistant cancer stem cells. This approach minimizes systemic toxicity while maximizing therapeutic efficacy, offering a cost-effective and clinically translatable solution for solid tumor therapy.</p> |
| title | SolidGel |
| url | https://doi.org/10.5281/zenodo.16954011 |